$43.49
3.84% today
NYSE, Jan 06, 10:00 pm CET

Conmed Corp. Stock price

$41.88
+1.81 4.52% 1M
-10.05 19.35% 6M
+1.28 3.15% YTD
-26.70 38.93% 1Y
-51.27 55.04% 3Y
-70.19 62.63% 5Y
-0.73 1.71% 10Y
+18.82 81.61% 20Y
NYSE, Closing price Mon, Jan 05 2026
+1.36 3.36%

Key metrics

Basic
Market capitalization
$1.3b
Enterprise Value
$2.1b
Net debt
$814.8m
Cash
$38.9m
Shares outstanding
31.0m
Valuation (TTM | estimate)
P/E
20.3 | 9.1
P/S
1.0 | 0.9
EV/Sales
1.6 | 1.5
EV/FCF
14.2
P/B
1.3
Dividends
DPS
$0.80
Yield 1Y | 5Y
1.9% | 0.8%
Growth 1Y | 5Y
0.0% | 0.0%
Payout 1Y | 3Y
18.8% | 66.5%
Increased
0 Years
Financials (TTM | estimate)
Revenue
$1.3b | $1.4b
EBITDA
$152.8m | $283.8m
EBIT
$118.0m | $215.2m
Net Income
$64.3m | $142.2m
Free Cash Flow
$148.7m
Growth (TTM | estimate)
Revenue
4.6% | 6.8%
EBITDA
-37.1% | 16.4%
EBIT
-43.2% | 2.9%
Net Income
-51.2% | 7.4%
Free Cash Flow
-10.7%
Margin (TTM | estimate)
Gross
54.2%
EBITDA
11.3% | 20.3%
EBIT
8.8%
Net
4.8% | 10.2%
Free Cash Flow
11.0%
Financial Health
Equity Ratio
41.7%
Return on Equity
13.8%
ROCE
5.9%
ROIC
4.3%
Debt/Equity
0.8
More
EPS
$2.1
FCF per Share
$4.8
Short interest
10.4%
Employees
4k
Rev per Employee
$340.0k
Show more

Is Conmed Corp. a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 7,084 stocks worldwide.

Conmed Corp. Stock Analysis

Unlock Scores for Free

Analyst Opinions

12 Analysts have issued a Conmed Corp. forecast:

6x Buy
50%
6x Hold
50%

Analyst Opinions

12 Analysts have issued a Conmed Corp. forecast:

Buy
50%
Hold
50%

Financial data from Conmed Corp.

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Sep '25
+/-
%
1,347 1,347
5% 5%
100%
- Direct Costs 617 617
8% 8%
46%
731 731
2% 2%
54%
- Selling and Administrative Expenses 523 523
22% 22%
39%
- Research and Development Expense 54 54
2% 2%
4%
153 153
37% 37%
11%
- Depreciation and Amortization 35 35
0% 0%
3%
EBIT (Operating Income) EBIT 118 118
43% 43%
9%
Net Profit 64 64
51% 51%
5%

In millions USD.

Don't miss a Thing! We will send you all news about Conmed Corp. directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Conmed Corp. Stock News

Neutral
Business Wire
one day ago
LARGO, Fla.--(BUSINESS WIRE)--CONMED Corporation (NYSE: CNMD) today announced that Patrick J. Beyer, President and Chief Executive Officer, and Todd W. Garner, Executive Vice President and Chief Financial Officer, will present at the 44th Annual J.P. Morgan Healthcare Conference at 3:00 p.m. PT (6:00 p.m. ET) on Monday, January 12, 2026 in San Francisco, CA. A live audio webcast of the presenta...
Neutral
Business Wire
one day ago
LARGO, Fla.--(BUSINESS WIRE)--CONMED Corporation (NYSE: CNMD) today announced that it will report financial results for the fourth quarter 2025 after the market close on Wednesday, January 28, 2026. The Company's management will host a conference call at 4:30 p.m. ET that same day to discuss the results. To participate in the conference call via telephone, please click here to pre-register and ...
Neutral
Business Wire
about one month ago
LARGO, Fla.--(BUSINESS WIRE)--CONMED Corporation (NYSE: CNMD) today announced its intention to exit its gastroenterology product lines as part of its broader portfolio optimization strategy. This exit allows CONMED to fully align operations and resources within its core markets—minimally invasive, robotic, and laparoscopic surgery, smoke evacuation, and the surgical treatment of orthopedic soft...
More Conmed Corp. News

Company Profile

CONMED Corp. operates as a medical technology company, which engages in the development, manufacture and sale of surgical devices and related equipment. It operates through the following geographical segments: United States; Americas excluding the United States; Europe, Middle East, and Africa; and Asia Pacific. Its products are used by surgeons and physicians in a variety of medical specialties, including orthopedic surgery, general surgery, gynecology, neurosurgery, thoracic surgery and gastroenterology. The company was founded by Eugene R. Corasanti in 1970 and is headquartered in Largo, FL.

Head office United States
CEO Patrick Beyer
Employees 3,900
Founded 1970
Website www.conmed.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today